4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-19-000296
Chief Business Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Klein Lawrence Otto · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-01-02 | Grant or award : show line 1 in the form | +20,000 | $29.87 | $597,400 | 20,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-02 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +20,000 | 20,000 | D |
Loading xslF345X03/doc4.xml…